{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:50:56Z","timestamp":1791647456172,"version":"4.3.4"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":427,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100001869","name":"Academia Sinica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001869","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,7]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      <jats:bold>Hepatitis B immunization has been documented to prevent fulminant hepatic failure (FHF) and hepatocellular carcinoma (HCC) by historical comparison studies in Taiwan. This study aimed to assess long-term risks and predictors of various liver diseases associated with incomplete immunization in 3.8 million vaccinees. Profiles of the National Hepatitis B Immunization Registry, National Cancer Registry, and National Death Certification Registry were linked to ascertain newly diagnosed cases of HCC and deaths from FHF and chronic liver diseases (CLDs) from infancy to early adulthood of 3,836,988 newborn vaccinees. Cox's proportional hazards models were used to estimate hazard ratios (HRs) for various risk predictors. There were 49 newly developed cases of HCC, 73 deaths from FHF, and 74 deaths from CLDs during the follow-up of 41,854,715 person-years. There were striking differences between unvaccinated and vaccinated newborns after the launch of a national immunization program for HCC incidence (0.293 vs. 0.117 per 100,000 person-years), FHF mortality (0.733 vs. 0.174 per 100,000 person-years), and CLD mortality (2.206 vs. 0.177 per 100,000 person-years). Among vaccinees, incomplete immunization was the most important risk predictor of HCC, FHF, and CLDs, showing an HR (95% confidence interval,<\/jats:bold>\n                      <jats:bold>P<\/jats:bold>\n                      <jats:bold>value) of 2.52 (1.25-5.05;<\/jats:bold>\n                      <jats:bold>P<\/jats:bold>\n                      <jats:bold>= 0.0094), 4.97 (3.05-8.11;<\/jats:bold>\n                      <jats:bold>P<\/jats:bold>\n                      <jats:bold>&lt; 0.0001), and 6.27 (3.62-10.84;<\/jats:bold>\n                      <jats:bold>P<\/jats:bold>\n                      <jats:bold>&lt; 0.0001), respectively, after adjustment for maternal hepatitis B serostatus.<\/jats:bold>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion :<\/jats:title>\n                    <jats:p>\n                      <jats:bold>Hepatitis B immunization can significantly prevent the long-term risk of HCC, FHF, and CLDs from infancy to early adulthood. Incomplete immunization with hepatitis B immunoglobulin or vaccines was the most important risk predictor of the liver disease among vaccinees. (Hepatology 2014;60:125\u2013132)<\/jats:bold>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/hep.27048","type":"journal-article","created":{"date-parts":[[2014,2,4]],"date-time":"2014-02-04T17:36:13Z","timestamp":1391535373000},"page":"125-132","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":56,"title":["Incomplete Hepatitis B Immunization, Maternal Carrier Status, and Increased Risk of Liver Diseases: A 20-Year Cohort Study of 3.8 Million Vaccinees"],"prefix":"10.1097","volume":"60","author":[{"given":"Yin-Chu","family":"Chien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chyi-Feng","family":"Jan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Ju","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsu-Sung","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"San-Lin","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Jen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-19-20250207","doi-asserted-by":"crossref","first-page":"582592","DOI":"10.1016\/S0140-6736(09)60207-5","article-title":"Hepatitis B virus infection.","volume":"373","author":"Liaw","year":"2009","journal-title":"Lancet"},{"key":"R2-19-20250207","doi-asserted-by":"crossref","first-page":"10461049","DOI":"10.1053\/jhep.2002.37084","article-title":"Interaction of hepatitis B virus, chemical carcinogen, and genetic susceptibility: multistage hepatocarcinogenesis with multifactorial etiology.","volume":"36","author":"Chen","year":"2002","journal-title":"Hepatology"},{"key":"R3-19-20250207","doi-asserted-by":"crossref","first-page":"198204","DOI":"10.1093\/infdis\/146.2.198","article-title":"Incidence of hepatitis B virus infections in preschool children in Taiwan.","volume":"146","author":"Beasley","year":"1982","journal-title":"J Infect Dis"},{"key":"R4-19-20250207","doi-asserted-by":"crossref","first-page":"168174","DOI":"10.1056\/NEJMoa013215","article-title":"Hepatitis B e antigen and the risk of hepatocellular carcinoma.","volume":"347","author":"Yang","year":"2002","journal-title":"N Engl J Med"},{"key":"R5-19-20250207","doi-asserted-by":"crossref","first-page":"628638","DOI":"10.1111\/j.1440-1746.2011.06695.x","article-title":"Natural history of chronic hepatitis B REVEALed.","volume":"26","author":"Chen","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"R6-19-20250207","doi-asserted-by":"crossref","first-page":"771774","DOI":"10.1056\/NEJM197504102921503","article-title":"Vertical transmission of hepatitis B antigen in Taiwan.","volume":"292","author":"Stevens","year":"1975","journal-title":"N Engl J Med"},{"key":"R7-19-20250207","doi-asserted-by":"crossref","first-page":"185190","DOI":"10.1093\/infdis\/147.2.185","article-title":"Postnatal infectivity of hepatitis B surface antigencarrier mothers.","volume":"147","author":"Beasley","year":"1983","journal-title":"J Infect Dis"},{"key":"R9-19-20250207","doi-asserted-by":"crossref","first-page":"13291339","DOI":"10.1093\/ije\/dyi206","article-title":"A mathematical model to estimate global hepatitis B disease burden and vaccination impact.","volume":"34","author":"Goldstein","year":"2005","journal-title":"Int J Epidemiol"},{"key":"R10-19-20250207","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00535-010-0304-7","article-title":"Natural history of hepatitis B virus infection: pediatric perspective.","volume":"46","author":"Ni","year":"2011","journal-title":"J Gastroenterol"},{"key":"R11-19-20250207","doi-asserted-by":"crossref","first-page":"25972603","DOI":"10.1001\/jama.1987.03390190075023","article-title":"A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigencarrier mothers.","volume":"257","author":"Chen","year":"1987","journal-title":"JAMA"},{"key":"R12-19-20250207","doi-asserted-by":"crossref","first-page":"126135","DOI":"10.1093\/epirev\/mxj010","article-title":"Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched.","volume":"28","author":"Chien","year":"2006","journal-title":"Epidemiol Rev"},{"key":"R13-19-20250207","doi-asserted-by":"crossref","first-page":"9699","DOI":"10.1002\/jmv.1890340205","article-title":"Seroprevalence of hepatitis B virus infection in children in Taipei, 1989: five years after a mass hepatitis B vaccination program.","volume":"34","author":"Tsen","year":"1991","journal-title":"J Med Virol"},{"key":"R14-19-20250207","doi-asserted-by":"crossref","first-page":"906908","DOI":"10.1001\/jama.1996.03540110060032","article-title":"Seroepidemiology of hepatitis B virus infection in children: ten years of mass vaccination in Taiwan.","volume":"276","author":"Chen","year":"1996","journal-title":"JAMA"},{"key":"R15-19-20250207","doi-asserted-by":"crossref","first-page":"367370","DOI":"10.1086\/314585","article-title":"Seroepidemiologic survey for hepatitis B virus infection in Taiwan: the effect of hepatitis B mass immunization.","volume":"179","author":"Hsu","year":"1999","journal-title":"J Infect Dis"},{"key":"R16-19-20250207","doi-asserted-by":"crossref","first-page":"471474","DOI":"10.1002\/jmv.10333","article-title":"Decline of hepatitis B carrier rate in vaccinated and unvaccinated subjects: sixteen years after newborn vaccination program in Taiwan.","volume":"69","author":"Lin","year":"2003","journal-title":"J Med Virol"},{"key":"R17-19-20250207","doi-asserted-by":"crossref","first-page":"759765","DOI":"10.1016\/j.vaccine.2005.08.062","article-title":"Hepatitis B virus infection in adolescents in a rural township: 15 years subsequent to mass hepatitis B vaccination in Taiwan.","volume":"24","author":"Lu","year":"2006","journal-title":"Vaccine"},{"key":"R18-19-20250207","doi-asserted-by":"crossref","first-page":"730735","DOI":"10.1016\/j.jhep.2012.05.021","article-title":"Minimization of hepatitis B infection by a 25year universal vaccination program.","volume":"57","author":"Ni","year":"2012","journal-title":"J Hepatol"},{"key":"R19-19-20250207","doi-asserted-by":"crossref","first-page":"e82e88","DOI":"10.1016\/j.ijid.2011.10.009","article-title":"Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20year period.","volume":"16","author":"Luo","year":"2012","journal-title":"Int J Infect Dis"},{"key":"R20-19-20250207","doi-asserted-by":"crossref","first-page":"18551859","DOI":"10.1056\/NEJM199706263362602","article-title":"Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group.","volume":"336","author":"Chang","year":"1997","journal-title":"N Engl J Med"},{"key":"R21-19-20250207","doi-asserted-by":"crossref","first-page":"30403042","DOI":"10.1001\/jama.284.23.3040","article-title":"Hepatitis B vaccination and hepatocellular carcinoma rates in boys and girls.","volume":"284","author":"Chang","year":"2000","journal-title":"JAMA"},{"key":"R22-19-20250207","doi-asserted-by":"crossref","first-page":"349352","DOI":"10.1067\/mpd.2001.116277","article-title":"Universal hepatitis B vaccination and the decreased mortality from fulminant hepatitis in infants in Taiwan.","volume":"139","author":"Kao","year":"2001","journal-title":"J Pediatr"},{"key":"R23-19-20250207","doi-asserted-by":"crossref","first-page":"5863","DOI":"10.1002\/hep.20006","article-title":"Pediatric fulminant hepatic failure in endemic areas of hepatitis B infection: 15 years after universal hepatitis B vaccination.","volume":"39","author":"Chen","year":"2004","journal-title":"Hepatology"},{"key":"R24-19-20250207","doi-asserted-by":"crossref","first-page":"13481355","DOI":"10.1093\/jnci\/djp288","article-title":"Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20year followup study.","volume":"101","author":"Chang","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"R25-19-20250207","doi-asserted-by":"crossref","first-page":"523527","DOI":"10.1007\/s10552-010-9721-4","article-title":"Reduction of hepatocellular carcinoma in childhood after introduction of selective vaccination against hepatitis B virus for infants born to HBV carrier mothers.","volume":"22","author":"Tajiri","year":"2011","journal-title":"Cancer Causes Control"},{"key":"R26-19-20250207","doi-asserted-by":"crossref","first-page":"801807","DOI":"10.1002\/hep.24442","article-title":"Elimination of hepatocellular carcinoma and acute hepatitis B in children 25 years after a hepatitis B newborn and catchup immunization program.","volume":"54","author":"McMahon","year":"2011","journal-title":"Hepatology"},{"key":"R27-19-20250207","doi-asserted-by":"crossref","first-page":"974976","DOI":"10.1001\/jama.2013.276701","article-title":"Thirtyyear outcomes of the national hepatitis B immunization program in Taiwan.","volume":"310","author":"Chiang","year":"2013","journal-title":"JAMA"},{"key":"R28-19-20250207","doi-asserted-by":"crossref","first-page":"10191027","DOI":"10.1093\/jnci\/djp146","article-title":"Hepatitis B Virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.","volume":"101","author":"Fwu","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"R29-19-20250207","doi-asserted-by":"crossref","first-page":"100106","DOI":"10.1086\/514610","article-title":"Failed postnatal immunoprophylaxis for hepatitis B: characteristics of maternal hepatitis B virus as risk factors.","volume":"27","author":"Ngui","year":"1998","journal-title":"Clin Infect Dis"},{"key":"R30-19-20250207","doi-asserted-by":"crossref","first-page":"135139","DOI":"10.1046\/j.1365-2893.1999.00145.x","article-title":"Hepatitis B virus vaccination and antenatal transmission of HBV markers to neonates.","volume":"6","author":"Vranckx","year":"1999","journal-title":"J Viral Hepatitis"},{"key":"R31-19-20250207","doi-asserted-by":"crossref","first-page":"123129","DOI":"10.1097\/01.inf.0000048677.32881.fa","article-title":"Antibody response to postexposure prophylaxis in infants born to hepatitis B surface antigenpositive women.","volume":"22","author":"Euler","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"R32-19-20250207","doi-asserted-by":"crossref","first-page":"12271231","DOI":"10.1086\/605698","article-title":"Vertical transmission of hepatitis B virus (HBV) from mothers negative for HBV surface antigen and positive for antibody to HBV core antigen.","volume":"200","author":"Walz","year":"2009","journal-title":"J Infect Dis"},{"key":"R33-19-20250207","first-page":"6669","article-title":"Horizontal transmission of hepatitis B virus in children.","volume":"16","author":"Hsu","year":"1993","journal-title":"J Pediatr Gastroenterol Nutr"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.27048","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201407000-00019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T12:05:30Z","timestamp":1738929930000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201407000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.27048","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}